In fibrotic lungs, PDGFR-β-dependent pathways appear to more strongly contribute to the progression of pulmonary fibrosis than those of PDGFR-α, and the specific inhibition of PDGFR-β, but not PDGFR-α effectively inhibits pulmonary fibrosis. Here, PDGFRB is linked to pulmonary fibrosis.